HI
ONC

HBK Investments’s BeOne Medicines Ltd ONC Stock Holding History

HBK Investments’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,443
Closed -$593K – 1463
2018
Q3 		$593K Buy
+3,443
New +$579K ﹤0.01% 882

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

HBK Investments's ONC Position: Q4 2018 in Review

HBK Investments sold out of BeOne Medicines Ltd (ONC) in Q4 2018, closing a stake of 3,443 shares — an estimated $593K sold.

HBK Investments first reported a position in ONC in Q3 2018 and held it in 1 quarter. The position peaked at $593K in Q3 2018. 192 funds tracked by Wall St. Rank hold ONC as of Q4 2018.

  • HBK Investments reported no remaining BeOne Medicines Ltd position as of Q4 2018 after selling out during the quarter.
  • HBK Investments sold 3,443 BeOne Medicines Ltd shares in Q4 2018, an estimated $593K.
  • HBK Investments first reported a position in BeOne Medicines Ltd in Q3 2018 and held it in 1 quarter.
  • HBK Investments's BeOne Medicines Ltd position peaked at $593K in Q3 2018.
  • 192 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2018.

Based on HBK Investments's 13F filing for Q4 2018, filed 14 Feb 2019.